Technology Evaluation
Center (TEC)

TEC is guided by the Medical Advisory Panel (MAP), which is composed of nationally respected physician experts. The MAP has final scientific and clinical authority for all TEC assessments.

Chaired by the Senior Vice President, Office of Clinical Affairs, Blue Cross Blue Shield Association, the MAP comprises experts in technology assessment, clinical research methodology and implementation and clinical practice. MAP membership is diversified to ensure representation by a wide variety of viewpoints within the healthcare community. A majority of members hold academic appointments and are independent medical experts without affiliation to healthcare payers.

Chairman

Trent Haywood, M.D., J.D.

Senior Vice President, Office of Clinical Affairs; Chief Medical Officer, Blue Cross and Blue Shield Association.

• Former Senior Vice President & Chief Medical Officer, VHA, Inc.
• Former Deputy Chief Medical Officer Centers for Medicare & Medicaid Services
• Oversees the National Council of Physician and Pharmacist Executives, senior BCBS Plan physicians that advise the Association
• Board-certified by the American Board of Internal Medicine

Co-Scientific Advisors (full biographic information following)

Mark A. Hlatky, M.D. 

Professor of Health Research and Policy and of Medicine (Cardiovascular Medicine),Stanford University School of Medicine:

Blue Cross and Blue Shield Association Medical Advisory Panel Members

Peter C. Albertsen, M.D.  Professor, Chief of Urology, and Residency Program Director, University of Connecticut HealthCenter:

Specialty:  Urology

• Member of the Patient Outcomes Research Team (PORT) II for Prostate Diseases and the National Cancer Institute Special Study of Prostate Cancer Health Care and Quality of Life
• Member of the Residency Review Committee for Urology of the Accreditation Council for Graduate Medical Education
• Editorial Board member of Urology and Urology Times; reviewer for JAMA, Cancer, Journal of the National Cancer Institute, and others
• Widely published author in the area of prostate disease
• Trustee of the American Board of Urology

Sarah T. Corley, M.D., F.A.C.P.  

Chief Medical Officer, NextGen Healthcare Information Systems, Inc:

American College of Physicians’ Appointee to the Blue Cross and Blue Shield Association Medical Advisory Panel

Specialty:  Internal Medicine, Medical Informatics

• Past-Governor, now member of the Governor’s Council, Virginia Chapter, American College of Physicians
• Commissioner, Certification Commission for Health Information Technology
• Board-certified in internal medicine

Helen Darling, M.A. 

President, National Business Group on Health:

• Purchaser/Consumer Representative
• President of NBGH, which has 280 mostly large employer members, including 58 of the Fortune 100. Provides solutions to the health care cost, quality and affordability crisis; serves as a link between large employers/purchasers and Congress, Executive Branch and other national organizations; the single voice for large employers on an array of health, productivity and disability issues.
• Board of Directors, National Quality Forum and Reagan-Udall Foundation; Member,InstituteofMedicineRoundtable on Evidence-Based Medicine, Committee on Performance Measurement, National Committee for Quality Assurance

Josef E. Fischer, M.D., F.A.C.S. 

William V. McDermott Professor of Surgery, Harvard Medical School:

• AmericanCollegeof Surgeons' Appointee to the Blue Cross and Blue Shield Association Medical Advisory Panel
• Specialty:  Surgery
• Widely published author and researcher, member of the editorial board of 15 national medical journals, associate editor of the Journal of the American College of Surgeons and the American Journal of Surgery. Editor of 14 texts of surgery, including the standard atlas of surgery, Mastery of Surgery, 5^th Edition
• Recipient of numerous research grants and professional honors, including the two most significant honors in surgery: the Distinguished Service Award from the AmericanCollegeof Surgeons and the Gold Medallion of the American Surgical Association. Selected as one of the 24 most prominent surgeons of the 20^th century by Archives of Surgery 1999. Former Chair of the Board of Regents of the American College of Surgeons, former Chair of the American Board of Surgery, and a member of the ACGME Residency Review Committee for Surgery
• Member of the Medicare Evidence Development and Coverage Advisory Committee
• Member of the Advisory Committee for the Institute for Clinical and Economic Research
• Recipient of numerous honorary fellowships from international surgical organizations
• Received an honorary MD from theUniversityofLund
• An Honorary Fellow of theRoyalCollegeof Surgeons inEdinburgh
• Author of over 850 peer-reviewed papers

Steven N. Goodman, M.D., M.H.S., Ph.D. 

Dean for Clinical and Translational Research, Stanford University School of Medicine, Professor, Departments of Medicine, Health Research and Policy:

Specialty:  Pediatrics, Biostatistics, Epidemiology

• Editor-in-Chief of Clinical Trials: Journal of the Society for Clinical Trials
• Senior statistical editor, Annals of Internal Medicine
• Co-chair, IOM Committee on Drug Safety
• Member of Methodology Committee, Patient-Centered Outcomes Research Institute
• Research and teaching focus on inferential and ethical issues in clinical research, peer review, evidence synthesis, diagnostic test evaluation, comparative effectiveness research
• Board-certified by the American Board of Pediatrics
• Co-Scientific Advisor to the Association’s Medical Advisory Panel
  

I. Craig Henderson, M.D.  

Adjunct Professor of Medicine,University of California, San Francisco:

Specialty: Oncology

• Former Chief of Medical Oncology and Associate Director of the Cancer Center at UCSF; former chairman of the Breast Cancer Committee of the Cancer and Acute Leukemia Group B (CALGB); former chairman of the Oncologic Drugs Advisory Committee of the Food and Drug Administration
• Vice chairman of theInstituteofMedicine Committeeon Technologies for the Early Detection of Breast Cancer
• Former chair of the World Health Organization (WHO) Committee on Essential Drugs (Cancer) and Participant in the WHO Expert Advisory Panel on Cancer
• Chairman of the Committee on Metastatic Breast Cancer of the Cochrane Collaboration on Meta-analyses.  Former chairman of the Early Breast Cancer Trialists Group (Oxfordmeta-analyses of breast cancer trials)
• Former CEO of SEQUUS Pharmaceuticals, Access Oncology, Inc., and former president of Keryx Biopharmaceuticals
• Founder of theBreastEvaluationCenterat the Dana-Farber Cancer Institute,HarvardMedicalSchool
• Associate editor, editorial board member and/or editorial advisory board for Breast Cancer Research and Treatment, European Journal of Cancer, The Breast, The Breast Journal, and Oncology

Jo Carol Hiatt, M.D., M.B.A., F.A.C.S. 

Chair, Inter-Regional New Technology Committee, Kaiser Permanente:

Specialty:  Surgery

• Staff Surgeon, Kaiser Permanente, Panorama City
• Assistant Clinical Professor of Surgery, UCLA
• Regional Assistant Medical Director, Business Management, Kaiser Permanente
• Chair, National Product Council, Kaiser Permanente
• Board-certified by the National Board of Medical Examiners and the American Board of Surgery

Mark A. Hlatky, M.D. 

Professor of Health Research and Policy and of Medicine (Cardiovascular Medicine),StanfordUniversitySchoolof Medicine:

American College of Cardiology Appointee to the Blue Cross and Blue Shield Association Medical Advisory Panel

Specialty:  Cardiology

• Director, Health Services Research Graduate Degree Program, Stanford University School of Medicine
• Director, Donald W. Reynolds Cardiovascular Clinical Research Center
• Former Co-Director, UCSF-Stanford Evidence-based Practice Center
• Attending, Cardiovascular Medicine Service, Stanford University School of Medicine
• Widely published researcher and editorial board member of several prestigious journals, including American Heart Journal and American Journal of Medicine

Saira A. Jan, M.S., Pharm.D. 

Associate Clinical Professor, Ernest Mario School of Pharmacy, Rutgers, The State University of New Jersey, Residency Director and Director of Clinical Programs Pharmacy Management, Horizon Blue Cross and Blue Shield of New Jersey:

• Specialty:  Clinical Pharmacy and Therapeutics
• Member of American Association of Health Plans (AHIP) advisory committee for Medication Therapy Management and Immunization
• Council for Affordable Quality Health Care (CAQH) National Committee;New JerseyStateRepresentative for Formulary Management
• Director of Research at Horizon Blue Cross Blue Shield ofNew Jersey
• Published in the areas of pharmacy benefit management, outcomes research, and clinical therapeutics
• Member of Pharmaceutical Assistance to Aged and Disabled (PAAD), Department of Health and Senior Services
• Member of Academy of Managed Care Pharmacy (AMCP)

Thomas Kowalski, R.Ph. 

Clinical Pharmacy Director, Blue Cross Blue Shield of Massachusetts:

Specialty:  Clinical Pharmacy and Therapeutics

• Member, Blue Cross and Blue Shield Association’s National Council of Physician and Pharmacy Executives
• Member, BCBSA’s Specialty Pharmacy Combined Capacity Steering Committee
• Leads the development, implementation, maintenance and evaluation of clinically appropriate and cost effective programs to control the escalating costs of pharmaceuticals and utilization trends on both medical and pharmacy benefits. 

Bernard Lo, M.D. 

Professor of Medicine and Director, Program in Medical Ethics, University of California, San Francisco:

Specialty:  Medical Ethics

• National Program Director, Greenwall Faculty Scholars in Bioethics Program
• Co-chair, Standards Working Ground of the California Institute for Regenerative Medicine
• Co-Director, Policy and Ethics Core, Center for AIDS Prevention Studies
• Member, Centers for Disease Control and Prevention Ethics Subcommittee
• Author of Resolving Ethical Dilemmas in Clinical Practice and of Ethical Issues in Clinical Research
• Board-certified in internal medicine

Randall E. Marcus, M.D.  

Charles H. Herndon Professor and Chairman, Department of Orthopaedics, Case Western Reserve University School of Medicine and University Hospitals Case Medical Center, Cleveland, Ohio:

Specialty:  Orthopedic Surgery

• American Board of Orthopaedic Surgery, Senior Director
• Clinical Orthopaedics and Related Research, Chairman Board of Trustees and Associate Editor
• Past President, American Board of Orthopaedic Surgery and past President of Association of Bone and Joint Surgeons
• Widely published in the area of orthopedics
• Board-certified by the American Board of Orthopaedic Surgery

Barbara J. McNeil, M.D., Ph.D.  

Ridley Watts Professor and Head, Department of Health Care Policy,HarvardMedicalSchool; Professor of Radiology, Brigham and Women's Hospital:

Specialty:  Technology Assessment/Quality of Care/Health Policy

• Member of Medicare Evidence Development and Coverage Advisory Committee
• Member, InstituteofMedicine
• Fellow, AmericanAcademyof Arts and Sciences
• Widely published author in the areas of radiology, cost-effectiveness analysis, and quality of care
• Board-certified by the National Board of Medical Examiners and the American Board of Nuclear Medicine

William R. Phillips, M.D., M.P.H.  

Clinical Professor of Family Medicine, University of Washington:

American Academy of Family Physicians appointee to the Blue Cross and Blue Shield Association Medical Advisory Panel

Specialty:  Family Medicine. Board-certified in family medicine and preventive medicine

• Co-Director, National Research Service Award Fellowship in Primary Care Research, University of Washington
• Senior Associate Editor, Annals of Family Medicine
• Senior Research Scientist, Centers for Public Health Research and Evaluation, Battelle Memorial  Institute,Seattle
• Member, Medicare Evidence Development and Coverage Advisory Committee
• Past-President, North American Primary Care Research Group
• Past-Chair,AmericanAcademyof Family Physicians Commission on Clinical Policies and Research
• Author of over 100 original peer-reviewed publications

Richard E. Rainey, M.D. 

Medical Director, Regence BlueShield of Idaho:

Specialty:  Pediatrics

• Chair, Blue Cross Blue Shield Association’s Medical Policy Panel
• Professional responsibilities include clinical integration and medical policy for Regence plans in Idaho, Oregon, Utah, and Washington
• Member of the American College of Physician Executives
• Formerly Associate Medical Director, BlueCross BlueShield of Tennessee
• Holds degrees in economics from Harvard and the University of Otago in New Zealand.
• Board-certified in pediatrics

Rita F. Redberg, M.D., M.Sc., F.A.C.C. 

Professor of Medicine and Director, Women's Cardiovascular Services, University of California San Francisco:

Specialty:  Cardiology

• Chief Editor of Archives of Internal Medicine
• Member of the American College of Cardiology's (ACC) Clinical Quality Committee and the Quality in Technology Work Group
• Member of the California Technology Assessment Forum, the Medical Policy Technology and Advisory Committee, and the U.S. Food and Drug Administration Cardiovascular Devices Expert Panel
• Robert Wood Johnson Health Policy Fellow, 2003-2006
• Board-certified in internal medicine and cardiovascular disease

Alan B. Rosenberg, M.D. 

Vice President, Medical Policy, Technology Assessment and Credentialing Programs, WellPoint, Inc.:

Specialty:  Internal Medicine

• Member, Blue Cross Blue Shield Association’s Medical Policy Panel
• Professional responsibilities include Medical Policy and Technology Assessment, Credentialing Programs, and Anthem Utilization Management Services, Inc.
• Board Member of URAC and the American Association of Preferred Provider Organizations (AAPPO)
• Plan Provider Technology Assessment Work Group; Agency for Healthcare Research and Quality (AHRQ) Effective Health Care Stakeholder Group; America’s Health Insurance Plans (AHIP) Cost Effectiveness Task Force and Vaccines and Immunization Workgroup; andAmericanCollegeof Cardiology Appropriateness Criteria for Echocardiography and CT Appropriate Use Technical Panel Participant
• Board-certified in internal medicine

Maren T. Scheuner, M.D., M.P.H., F.A.C.M.G.  

Clinical Genetics and Principal Investigator, Health Services Genomics Program, VA Greater Los Angeles Healthcare System; Health Sciences Associate Clinical Professor, Department of Medicine, David Geffen School of Medicine at UCLA; Natural Scientist, RAND Corporation:

American College of Medical Genetics Appointee to the Blue Cross and Blue Shield Association Medical Advisory Panel

Specialty:  Medical Genetics, Internal Medicine

• Member, American Board of Medical Genetics, Board of Directors
• Member, Medicare Evidence Development and Coverage Advisory Committee
• Board-certified in medical genetics

J. Sanford Schwartz, M.D., F.A.C.P.  

Leon Hess Professor of Medicine and Health Management & Economics,School of Medicine and TheWhartonSchool,University of Pennsylvania:

Specialty: Internal Medicine (ABIM certified)

• Research Interests: medical decision making; health economics (cost-effectiveness analysis, cost-quality tradeoffs); assessment of medical interventions/technology assessment; adoption/diffusion medical innovation
• UniversityofPennsylvania: Former Executive Director, Leonard Davis Institute of Health Economics; Former Co–Director, Robert Wood Johnson Clinical Scholars Program; Former Director, Cancer Center Program in Health Economics and Health Services Research; University of Pennsylvania
• National Professional and Research Societies: Past–President, Society for Medical Decision Making; Past–President, American Federation for Clinical Research
• National Advisory Committees: National Cholesterol Education Project Adult Treatment Panels III and IV (NCEP–ATP), National Heart Lung and Blood Institute; National Advisory Committee, Robert Wood Johnson Minority Faculty Development Committee; Board of Directors ECRI Institute; Member US Preventive Services Task Force; Elected memberships: Institute of Medicine National Academy of Sciences; Association of American Physicians; American Society for Clinical Investigation; American Clinical and Climatological Society

Earl P. Steinberg, M.D., M.P.P.  

Executive Vice President, Innovation and Dissemination & Chief, Geisinger Healthcare Solutions Enterprise:

Specialty:  Technology Assessment/Internal Medicine

• Adjunct Professor of Medicine (Johns Hopkins School of Medicine) and of Health Policy and Management (Johns Hopkins School of Hygiene and Public Health)
• Areas of expertise include technology assessment, cost and effectiveness of alternative patterns of medical practice, clinical practice guideline development, methods for evaluating quality of care, strategies for improving quality of care, and the clinical and economic impacts of health care payment innovations
• Fellow of the American College of Physicians – American Society of Internal Medicine
• Board-certified in internal medicine